Organisation
Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO)
Research Group
Projects
1 - 10 of 161
- Development of novel TCO probes for pretargeted intracellular PET imaging.From1 Oct 2018 → 31 Oct 2019Funding: BOF - Other initiatives
- Targeting Polo-like kinase 1 for treatment of NSCLC patients: focus on the induction of cellular senescence, the TP53 status and hypoxia.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Plasma-treated liquids for cancer treatment: elucidating the selectivity against cancer cells by a combined experimental and computational study.From1 Oct 2018 → 31 Jan 2019Funding: FWO fellowships
- Study towards molecular heterogeneity of circulating tumor cells and their representation of metastatic sites in patients with metastatic breast cancer.From1 Oct 2018 → 30 Sep 2021Funding: FWO fellowships
- Imaging of receptor activator of the nuclear factor κ B ligand (RANKL) tumor microenvironment using immuno-positron emission tomography (PET) in models of head-and-neck and breast cancer.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Exploring the potential and underlying mechanisms of therapeutic activation of p53 in combination with immunotherapy to stimulate an innate immune response against non-small cell lung cancer.From1 Oct 2018 → 30 Sep 2020Funding: FWO fellowships
- The role of infiltrating immune cells in the aggresive phenotype of inflammatory breast cancer and possible new (immuno)therapeutic targets.From1 Oct 2018 → 30 Sep 2020Funding: FWO fellowships
- Development of novel cell death PET imaging probes for early treatment response assessment.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Developing a novel synergistic approach of chemotherapy and immunotherapy to enhance the anti-tumor immune response in non-small cell lung cancer.From1 Oct 2018 → 30 Sep 2022Funding: BOF - Doctoral projects
- Research in the field of oncology.From1 Oct 2018 → TodayFunding: BOF - ZAP BOF mandates, BOF - Research professorship
Publications
1431 - 1440 of 1626
- Molecular profiles to biology and pathways: a systems biology approach(2016)
Authors: Steven Van Laere, Luc Dirix, Peter Vermeulen
- Deep Brain Stimulation for epilepsy(2009)
Authors: Tine Wyckhuys, P.J. Geerts, R. Raedt, K. Vonck, W. Wadman, P. Boon
Pages: 63 - 80 - Seizures in the intrahippocampal kainic acid epilepsy model(2009)
Authors: R. Raedt, A. van Dycke, D. van Merelbeke, T. de Smedt, P. Claeys, Tine Wyckhuys, K. Vonck, W. Wadman, P. Boon
Pages: 293 - 303 - In vivo evaluation in rodents of $[^{123}I]-3-I-CO$ as a potential SPECT tracer for the serotonin $5-HT_{2A}$ receptor(2008)
Authors: Peter M. Blanckaert, Ingrid Burvenich, Leonie Wyffels, Sylvie De Bruyne, Lieselotte Moerman, Filip De Vos
Pages: 861 - 867 - An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial(2008)
Authors: Christopher Wood, Pramod Srivastava, Ronald Bukowski, Jan Vermorken, [et al.]
Pages: 145 - 154 - Phase 3 randomised study of canfosfamide (Telcyta®, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer(2009)
Authors: I. Vergote, N. Finkler, J. del Campo, A. Lohr, J. Hunter, D. Matei, J. Kavanagh, Jan Vermorken, L. Meng, M. Jones, et al.
Pages: 2324 - 2332 - Effect of cyclosporin A administration on the biodistribution and multipinhole $\mu$SPECT imaging of $[^{123}I]$R91150 in rodent brain(2009)
Authors: P. Blanckaert, I. Burvenich, Steven Staelens, S. de Bruyne, L. Moerman, Leonie Wyffels, F. de Vos
Pages: 446 - 453 - AB-OSEM reconstruction for improved kinetic parameter estimation(2010)
Authors: Jeroen Verhaeghe, Andrew J. Reader
Pages: 2638 - 2642 - Noninvasive whole-body imaging of phosphatidylethanolamine as a cell death marker using $^{99m}Tc-duramycin$ during TNF-induced SIRS(2018)
Authors: Tinneke Delvaeye, Leonie Wyffels, Steven Deleye, Kelly Lemeire, Amanda Gonçalves, Elke Decrock, Steven Staelens, Luc Leybaert, Peter Vandenabeele, Dmitri Krysko
Pages: 1140 - 1145 - Efficacy of cabazitaxel in castration-resistant prostate cancer is independent of the presence of AR-V7 in circulating tumor cells(2015)
Authors: Wendy Onstenk, Anieta M. Sieuwerts, Jaco Kraan, Mai Van, Annemieke J. M. Nieuweboer, Ron H. J. Mathijssen, Paul Hamberg, Hielke J. Meulenbeld, Bram De Laere, Luc Dirix, et al.
Pages: 939 - 945